qualify for semaglutide What BMI Do You Need to GLP-1? Semaglutide Injections Kirkland & Bellevue

Depending on your dose and individual health factors, they may recommend a short washout period or a direct transition

Declarations Ethics Not applicable

Potential Side Effects & Safety Measures Semaglutide is generally well-tolerated but may cause: Gastrointestinal symptoms, such as nausea, constipation, diarrhoea Rare headache or fatigue Clinics offer strategies to ease these effects

The company that manufactures semaglutide has since licensed a version for use in weight loss (called Wegovy)

GLP-1 functions to delay gastric emptying, stimulate insulin secretion and mediate satiety in the central nervous system (CNS), all actions that are beneficial to individuals with obesity and type 2 diabetes

Clinicians should: Assess baseline HbA1c and current glycemic control before discontinuation Implement or intensify alternative therapies (metformin, SGLT2 inhibitors, or other agents) before or concurrent with tirzepatide cessation Increase home glucose monitoring frequency for several weeks post-discontinuation Schedule follow-up to evaluate metabolic stability Special consideration for insulin or sulfonylurea users : Patients taking these medications alongside tirzepatide may need proactive dose adjustments when stopping tirzepatide to prevent hypoglycemia